Your search returned 187 studies. (Get alerts for new studies):
- Evaluation of Effective Lens Position With a Uniplanar Bi-aspheric IOL
Conditions: Cataract
Location: Rome, Georgia
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Rome, Georgia
- Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
Conditions: Leukemia
Location: Chattanooga, Tennessee
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Rome, Georgia
- Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Conditions: Kidney Cancer
Location: Chattanooga, Tennessee
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Rome, Georgia
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Rome, Georgia
- Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment
Location: Chattanooga, Tennessee
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
Location: Rome, Georgia
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
Location: Rome, Georgia
- Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
Conditions: Haemophilus Infections - Diphtheria - Tetanus - Polio - Pertussis
Location: Cartersville, Georgia
- Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
Conditions: Haemophilus Infections - Diphtheria - Tetanus - Polio - Pertussis
Location: Jasper, Georgia
- S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Rome, Georgia
- Eslicarbazepine Acetate Monotherapy Long Term Study
Conditions: Epilepsy
Location: Rome, Georgia
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Rome, Georgia
- S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Rome, Georgia
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Rome, Georgia
- Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
Conditions: Thrombocytopaenia
Location: Rome, Georgia
- Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age
Conditions: Hypertension
Location: Dalton, Georgia
- An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6
Conditions: Hypertension
Location: Dalton, Georgia
- A Study in Second Line Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Rome, Georgia
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Rome, Georgia
- A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Conditions: Advanced Prostate Cancer - Prostatic Neoplasms
Location: Cartersville, Georgia
- A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Conditions: Advanced Prostate Cancer - Prostatic Neoplasms
Location: Rome, Georgia
- A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
Conditions: Cardiovascular Disease, Rheumatoid Arthritis
Location: Rome, Georgia
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Rome, Georgia
- A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Chi
Conditions: Vaccines - Meningococcal Vaccines
Location: Dalton, Georgia
- Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention
Conditions: Myocardial Infarction - Acute Coronary Syndromes - Unstable Angina
Location: Rome, Georgia
- A Study of LY2940680 in Small Cell Lung Cancer
Conditions: Small Cell Lung Carcinoma
Location: Rome, Georgia
- A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer
Conditions: Squamous Non Small Cell Lung Cancer
Location: Rome, Georgia
- Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neurob
Conditions: Disseminated Neuroblastoma - Localized Resectable Neuroblastoma - Localized Unresectable Neuroblastoma - Regional Neuroblastoma - Stage 4S Neuroblastoma
Location: Chattanooga, Tennessee
- Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastom
Conditions: Brain and Central Nervous System Tumors
Location: Chattanooga, Tennessee
- Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Conditions: Fetal Membranes, Premature Rupture
Location: Chattanooga, Tennessee
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Chattanooga, Tennessee
- Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surge
Conditions: Kidney Cancer
Location: Chattanooga, Tennessee
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Conditions: Sarcoma
Location: Chattanooga, Tennessee
- Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms Tumor
Conditions: Kidney Cancer - Metastatic Cancer
Location: Chattanooga, Tennessee
- A Pivotal Study of a Facet Replacement System to Treat Spinal Stenosis
Conditions: Lumbar Spinal Stenosis
Location: Chattanooga, Tennessee
- A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chr
Conditions: Myelogenous Leukemia, Chronic
Location: Chattanooga, Tennessee
- Protocolized Care for Early Septic Shock
Conditions: Sepsis - Severe Sepsis - Septic Shock
Location: Nashville, Tennessee
- Rituximab, Lenalidomide, and Bortezomib in Mantle Cell Lymphoma
Conditions: Mantle Cell Lymphoma
Location: Chattanooga, Tennessee
- Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer
Location: Chattanooga, Tennessee
- Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Conditions: Myelogenous Leukemia, Chronic
Location: Chattanooga, Tennessee
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic S
Location: Chattanooga, Tennessee
- Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Pa
Conditions: Diffuse Large B-cell Lymphoma
Location: Chattanooga, Tennessee
- Airway Pressure Release Ventilation (APRV) Compared to ARDSnet Ventilation
Conditions: Acute Lung Injury - Adult Respiratory Distress Syndrome - Kidney Injury
Location: Chattanooga, Tennessee
- Post-Approval Clinical Study of the Talent Thoracic Stent Graft to Treat Thoracic Aortic Aneurysms (THRIVE)
Conditions: Thoracic Aortic Aneurysms
Location: Chattanooga, Tennessee
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Chattanooga, Tennessee
- A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Conditions: Asthma
Location: Chattanooga, Tennessee
- Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
Conditions: Haemophilus Infections - Diphtheria - Tetanus - Polio - Pertussis
Location: Chattanooga, Tennessee
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Chattanooga, Tennessee
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Chattanooga, Tennessee
- Collecting Tumor Samples From Patients With Gynecological Tumors
Conditions: Cancer
Location: Chattanooga, Tennessee
- Study of Kidney Tumors in Young Patients
Conditions: Kidney Cancer - Nonneoplastic Condition
Location: Chattanooga, Tennessee
- Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
Conditions: Sarcoma
Location: Chattanooga, Tennessee
- Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
Conditions: Sarcoma
Location: Chattanooga, Tennessee
- Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Chattanooga, Tennessee
- Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Conditions: Neuroblastoma
Location: Chattanooga, Tennessee
- Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer
Location: Chattanooga, Tennessee
- Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Conditions: Atrial Fibrillation - Arrhythmia
Location: Chattanooga, Tennessee
- Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
Conditions: Chordoma - Desmoid Tumor - Sarcoma
Location: Chattanooga, Tennessee
- Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
Conditions: Brain and Central Nervous System Tumors
Location: Chattanooga, Tennessee
- Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lympho
Conditions: Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
Location: Chattanooga, Tennessee
- Study of Blood Samples From Newborns With Down Syndrome
Conditions: Leukemia
Location: Chattanooga, Tennessee
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
Conditions: Liver Cancer
Location: Chattanooga, Tennessee
- Electronic Brachytherapy for the Treatment of NMSC
Conditions: Basal Cell Carcinoma - Squamous Cell Carcinoma
Location: Chattanooga, Tennessee
- Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Chattanooga, Tennessee
- Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Conditions: Pancreatic Cancer - Ductal Adrenocarcinoma - Exocrine Pancreatic Cancer
Location: Chattanooga, Tennessee
- Prevention of Infection in Surgical Treatment of Closed Fractures: Comparative of Cefazolin vs Vancomycin
Conditions: Closed Fractures
Location: Chattanooga,, Tennessee
- Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis
Conditions: Deep Venous Thrombosis
Location: Chattanooga,, Tennessee
- Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
Location: Chattanooga, Tennessee
- Phase II Study for the Evaluation of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Wh
Conditions: Multiple Myeloma
Location: Chattanooga, Tennessee
- Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)
Conditions: Breast Cancer
Location: Chattanooga, Tennessee
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Chattanooga, Tennessee
- Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locall
Conditions: Bladder Cancer
Location: Chattanooga, Tennessee
- A Study to Determine if There is a Possible Association Between Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) and Phosphodiesterase Type 5 (
Conditions: Nonarteritic Anterior Ischemic Optic Neuropathy
Location: Chattanooga, Tennessee
- A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Patients With Hepa
Conditions: Hepatocellular Carcinoma
Location: Chattanooga, Tennessee
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Chattanooga, Tennessee
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Chattanooga, Tennessee
- Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Conditions: Ovarian Cancer
Location: Chattanooga, Tennessee
- Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Conditions: Ovarian Cancer
Location: Chattanooga, Tennessee
- A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma
Conditions: Gastric Cancer
Location: Chattanooga, Tennessee
- Study Evaluating the Safety and Efficacy of Onartuzumab (Metmab) And/Or Bevacizumab in Combination With Paclitaxel in Patients With Metastatic, Triple
Conditions: Breast Cancer
Location: Chattanooga, Tennessee
- Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Chattanooga, Tennessee
- Topical Lidocaine on the Cervix and Intra-Cervical Prior to Insertion of Intrauterine Devices
Conditions: Contraception
Location: Chattanooga, Tennessee
- Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Conditions: Metastatic Renal Cell Carcinoma
Location: Chattanooga, Tennessee
- FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only
Conditions: Colorectal Cancer
Location: Chattanooga, Tennessee
- CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Conditions: Chronic Myelogenous Leukemia in Chronic Phase
Location: Chattanooga, Tennessee
- Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Conditions: Fungal Infection - Leukemia - Neutropenia
Location: Chattanooga, Tennessee
- Day Zero Urinary Catheter Removal in Gen Thoracic Surgery Patients
Conditions: Postoperative Retention of Urine - Postoperative Urinary Tract Infection
Location: Chattanooga, Tennessee
- National Marrow Donor Program Long-Term Donor Follow-Up
Conditions: Hematologic Neoplasms
Location: Chattanooga, Tennessee
- Proteomic Assessment of Preterm Birth
Conditions: Preterm Birth
Location: Chattanooga, Tennessee
- Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
Conditions: Adult Acute Erythroid Leukemia (M6) - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic Leukem
Location: Chattanooga, Tennessee
- Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients
Conditions: Proteinuria - Idiopathic Membranous Nephropathy
Location: Chattanooga, Tennessee
- Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Conditions: Acute Kidney Injury
Location: Chattanooga, Tennessee
- Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Conditions: Acute Kidney Injury
Location: Chattanooga, Tennessee
- Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy
Conditions: Metastatic Breast Cancer
Location: Chattanooga, Tennessee
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Neurotoxicity - Pain - Therapy-related Toxicity
Location: Chattanooga, Tennessee
- Patient Reported Symptoms in Ovarian Cancer (PRECISION)
Conditions: Ovarian Cancer
Location: Chattanooga, Tennessee
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Chattanooga, Tennessee
- A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
Location: Chattanooga, Tennessee
- A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Patients With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have R
Conditions: Non-Small Cell Lung Cancer
Location: Chattanooga, Tennessee
- Safety and Effectiveness Trial of the Ventana Fenestrated Stent Graft System
Conditions: Abdominal Aortic Aneurysm
Location: Chattanooga, Tennessee
- Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Typ
Conditions: Diabetes Type 2
Location: Chattanooga, Tennessee
- Study of BMS-936558 Compared to Docetaxel in Previously Treated Advanced or Metastatic Non-squamous NSCLC
Conditions: Non-Squamous Cell Non-small Cell Lung Cancer
Location: Chattanooga, Tennessee
- A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris
Conditions: Acne Vulgaris
Location: Chattanooga, Tennessee
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Chattanooga, Tennessee
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Chattanooga, Tennessee
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Chattanooga, Tennessee
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Chattanooga, Tennessee
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid
Location: Hixson, Tennessee
- ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
Conditions: Neoplasms, Breast - Breast Cancer
Location: Chattanooga, Tennessee
- ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
Conditions: Neoplasms, Breast - Breast Cancer
Location: Chattanooga, Tennessee
- Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
Conditions: Endometrial Cancer
Location: Chattanooga, Tennessee
- Condition of Approval Study
Conditions: Lumbar Spinal Stenosis
Location: Chattanooga, Tennessee
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
Location: Chattanooga, Tennessee
- Juvenile Idiopathic Arthritis (JIA) Registry
Conditions: Juvenile Idiopathic Arthritis
Location: Hixson, Tennessee
- Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Conditions: Healthy
Location: Chattanooga, Tennessee
- Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
Conditions: Stroke
Location: Chattanooga, Tennessee
- Trial of Poor Performance Status Patients (ToPPS)
Conditions: Non Small Cell Lung Cancer
Location: Chattanooga, Tennessee
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Chattanooga, Tennessee
- Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Conditions: Leukaemia, Lymphocytic, Chronic
Location: Chattanooga, Tennessee
- INSIGHT Influenza Hospitalization Study (FLU 003)
Conditions: Influenza - (Influenza A and Subtypes Such as H3N2 and 2009 H1N1 or Influenza B)
Location: Chattanooga, Tennessee
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Chattanooga, Tennessee
- A Study of LY2127399 in Patients With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus - Connective Tissue Disease - Autoimmune Disease
Location: Hixon, Tennessee
- Single Agent Ofatumumab Vs. Single Agent Rituximab in Follicular Lymphoma Relapsed After Rituximab-Containing Therapy
Conditions: Lymphoma, Follicular
Location: Chattanooga, Tennessee
- Post-Myocardial Infarction Remodeling Prevention Therapy
Conditions: Acute Myocardial Infarction - Pacing Therapy - Cardiac Remodeling - Heart Failure
Location: Chattanooga, Tennessee
- Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 Hours
Conditions: Stroke
Location: Chattanooga, Tennessee
- Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyos
Conditions: Adult Rhabdomyosarcoma - Alveolar Childhood Rhabdomyosarcoma - Mixed Childhood Rhabdomyosarcoma - Pleomorphic Childhood Rhabdomyosarcoma - Previously Treated Childhood Rhabdomyosarcoma - Recurrent Adult Soft Tissue Sarcoma - Recurrent Childhood Rhabdomyos
Location: Chattanooga, Tennessee
- A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Conditions: Cancer
Location: Chattanooga, Tennessee
- A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001 AM2)
Conditions: Clostridium Difficile Infection
Location: Chattanooga, Tennessee
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Recurrent Melanoma - Stage IIIB Melanoma - Stage IIIC Melanoma - Stage IV Melanoma
Location: Chattanooga, Tennessee
- A Study of Obinutuzumab (RO5072759) in Combination With CHOP Chemotherapy Versus MabThera/Rituxan (Rituximab) With CHOP in Patients With CD20-Positive
Conditions: Lymphoma, B-Cell
Location: Chattanooga, Tennessee
- Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics
Conditions: Type I Diabetes
Location: Chattanooga, Tennessee
- Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer
Conditions: Prostate Cancer
Location: Chattanooga, Tennessee
- BAY81-8973 Pediatric Safety and Efficacy Trial
Conditions: Haemophilia A
Location: Chattanooga, Tennessee
- A Study of First-line Maintenance Tarceva (Erlotinib) Versus Tarceva at Time of Disease Progression in Patients With Advanced Non-small Cell Lung Canc
Conditions: Non-Small Cell Lung Cancer
Location: Chattanooga, Tennessee
- A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer
Conditions: Breast Cancer
Location: Chattanooga, Tennessee
- A Study to Assess Efficacy and Safety With VESIcare® to Improve Urinary Continence in Subjects After Robotic Assisted Radical Prostatectomy
Conditions: Urinary Incontinence
Location: Chattanooga, Tennessee
- Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
Conditions: Anxiety Disorder - Fallopian Tube Cancer - Fatigue - Nausea and Vomiting - Neurotoxicity - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Chattanooga, Tennessee
- A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometri
Conditions: Solid Tumors and Advanced Endometrial Cancer - Endometrial Cancer - Second-line Treatment - VEGF
Location: Chattanooga, Tennessee
- Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Conditions: Uncontrolled Hypertension
Location: Chattanooga, Tennessee
- A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Patients With HER2-Positive Breast Cancer Who Have Received at
Conditions: Breast Cancer
Location: Chattanooga, Tennessee
- Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Patients Resistant to Aromatase Inhibitor
Conditions: Breast Cancer
Location: Chattanooga, Tennessee
- A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa (Amgen) in Patients With Chronic Renal Failure Requiring Hemodia
Conditions: Chronic Kidney Disease - Chronic Renal Failure
Location: Chattanooga, Tennessee
- TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cancer
Location: Chattanooga, Tennessee
- A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Conditions: Irritable Bowel Syndrome
Location: Chattanooga, Tennessee
- Combining Lesinurad With Allopurinol in Inadequate Responders
Conditions: Gout
Location: Chattanooga, Tennessee
- Study of Zevalin Versus Observation in Patients at Least 60 Yrs Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in PET-negative Complete Remiss
Conditions: Diffuse Large B-cell Lymphoma - Follicle Center Lymphoma
Location: Chattanooga, Tennessee
- Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
Conditions: Tophaceous Gout
Location: Chattanooga, Tennessee
- A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To
Conditions: Rheumatoid Arthritis
Location: Hixson, Tennessee
- Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
Conditions: Irritable Bowel Syndrome With Diarrhea
Location: Chattanooga, Tennessee
- Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J
Conditions: Irritable Bowel Syndrome
Location: Chattanooga, Tennessee
- Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J
Conditions: Irritable Bowel Syndrome
Location: Chattanooga, Tennessee
- Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
Conditions: Down Syndrome - Fetal Aneuploidy
Location: Chatanooga, Tennessee
- A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
Conditions: Hemophilia A
Location: Chattanooga, Tennessee
- Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients
Conditions: Diabetic Nephropathy
Location: Chattanooga, Tennessee
- Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abir
Conditions: Prostate Cancer - Castration Resistant Prostate Cancer - Pain - Prostatic Neoplasms
Location: Chattanooga, Tennessee
- An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)
Conditions: Breast Cancer
Location: Chattanooga, Tennessee
- Study of BMS-936558 Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC)
Conditions: Squamous Cell Non-small Cell Lung Cancer
Location: Chattanooga, Tennessee
- Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04)
Conditions: Rheumatoid Arthritis
Location: Hixson, Tennessee
- Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
Conditions: Invasive Ductal Carcinoma - Ductal Carcinoma in Situ
Location: Chattanooga, Tennessee
- A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)
Conditions: Asthma
Location: Chattanooga, Tennessee
- Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer
Location: Chattanooga, Tennessee
- A Randomized, Controlled Study Evaluating the Efficacy and Safety of GS-1101 (CAL-101) in Combination With Ofatumumab for Previously Treated Chronic L
Conditions: Chronic Lymphocytic Leukemia
Location: Chattanooga, Tennessee
- The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist
Conditions: Diabetes - Diabetes Mellitus, Type 2
Location: Chattanooga, Tennessee
- A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease
Conditions: Diabetic Kidney Disease
Location: Chattanooga, Tennessee
- Phase 2 Study of TD-9855 to Treat Fibromyalgia
Conditions: Fibromyalgia
Location: Chattanooga, Tennessee
- A Study of MK-3102 in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019 AM3)
Conditions: Type 2 Diabetes Mellitus
Location: Chattanooga, Tennessee
- A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018 AM5)
Conditions: Type 2 Diabetes Mellitus
Location: Chattanooga, Tennessee
- NOLAN: Naproxen or Loratadine and Neulasta
Conditions: Bone Pain in Stage I - III Breast Cancer
Location: Chattanooga, Tennessee
- A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2
Conditions: Type 2 Diabetes Mellitus
Location: Chattanooga, Tennessee
- A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities
Conditions: Cardiovascular Disease, Diabetes Mellitus, Type 2
Location: Chattanooga, Tennessee
- A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities
Conditions: Cardiovascular Disease, Diabetes Mellitus, Type 2
Location: Chattanooga, Tennessee
- Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes
Conditions: Diabetes - Diabetes Mellitus, Type 2
Location: Chattanooga, Tennessee
- The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Conditions: Irritable Bowel Syndrome Characterized by Constipation
Location: Chattanooga, Tennessee
- CORRECT: COmmunity RegistRy Study Evaluating Dupuytren's Contracture Treatment
Conditions: Dupuytren's Contracture
Location: Chattanooga, Tennessee
- STEAM: A Study of Sequential and Concurrent FOLFOXIRI/Avastin (Bevacizumab) Regimens Versus FOLFOX/Avastin in First-Line in Patients With Metastatic C
Conditions: Colorectal Cancer
Location: Chattanooga, Tennessee
- Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients
Conditions: Type 2 Diabetes
Location: Chattanooga, Tennessee
- A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer
Conditions: Squamous Non Small Cell Lung Cancer
Location: Chattanooga, Tennessee
- Safety, Efficacy and Pharmacokinetics of ALD403
Conditions: Migraine
Location: Chattanooga, Tennessee
- Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2
Location: Chattanooga, Tennessee
- Study the Characteristics of Cardiac Related Events in Hemodialysis Patients
Conditions: End Stage Renal Disease
Location: Chattanooga, Tennessee
- Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Conditions: Chronic Myelogenous Leukemia
Location: Chattanooga, Tennessee
- A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
Conditions: Type 1 Diabetes Mellitus
Location: Chattanooga, Tennessee
- CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects W
Conditions: Type 1 Diabetes Mellitus
Location: Chattanooga, Tennessee
- MLN9708 Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma
Location: Chattanooga, Tennessee
|